Table 1.
Cell Line (Tumor Type) |
Initial IC50 (µM) | Drug-Resistance Induction Protocol | Final IC50 (µM) | RI | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Step 1 | Step 2 | Step 3 | Step 4 | Step 5 | Step 6 | Step 7 | Step 8 | ||||
T-CDS-17#4 (chondros.) |
0.088 | 0.008 µM (IC20) 1 month |
0.016 µM (2 × IC20) 1 month |
0.032 µM (4 × IC20) 1 month |
0.064 µM (8 × IC20) 1 month |
- | - | - | - | 1.3 | 15.2 |
MG-63 (osteos.) |
0.061 | 0.019 µM (IC20) 1 month |
0.038 µM (2 × IC20) 1 month |
0.076 µM (4 × IC20) 1 month |
0.152 µM (8 × IC20) 1 month |
0.304 µM (16 × IC20) 1 month |
- | - | - | 1.4 | 23.7 |
Saos-2 (osteos.) |
0.037 | 0.006 µM (IC20) 1 month |
0.012 µM (2 × IC20) 1 month |
0.024 µM (4 × IC20) 1 month |
- | - | - | - | - | 1.7 | 44.9 |
143-B (osteos.) |
0.049 | 0.010 µM (IC20) 1 month |
0.020 µM (2 × IC20) 1 month |
0.040 µM (4 × IC20) 1 month |
0.080 µM (8 × IC20) 1 month |
0.160 µM (16 × IC20) 1 month |
0.320 µM (32 × IC20) 1 month |
0.640 µM (64 × IC20) 1 month |
1.280 µM (128 × IC20) 1 month |
6.4 | 131.4 |
Abbreviations: chondros, chondrosarcoma; osteos, osteosarcoma.